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Abstract We investigated to what extent different types of NO
donors induce caspase activation by opening of the mitochondrial
permeability transition pore (PTP) or inhibition of mitochondrial
respiration. We found that nitrosothiols can directly open the
PTP in isolated mitochondria and cause cytochrome c release,
whereas NONOate donors can not. In macrophages nitrosothiols
cause caspase activation that is blocked by cyclosporin A or
calcium chelation, both of which prevent PTP opening, whereas
caspase activation caused by NONOates is much less sensitive to
these agents. Inhibitors of mitochondrial respiration did not
promote PTP opening in isolated mitochondria, and although
they cause caspase activation in macrophages, this activation was
slower than that caused by NO donors, and was relatively
insensitive to cyclosporin and calcium chelators suggesting that
PTP opening was not involved.
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1. Introduction
Nitric oxide (NO) can induce caspase-mediated apoptosis in
a variety of cell types, including macrophages, thymocytes,
pancreatic islets and neurons (reviewed in [1,2]). NO-induced
apoptosis may be important in macrophage-induced killing of
tumour cells, beta-cell destruction in insulin-dependent diabe-
tes, in£ammatory diseases, neurodegenerative diseases and
vascular disease (reviewed in [3,4]). The mechanisms by which
NO induces caspase activation in cells are however unclear.
Suggested mechanisms include the following. (A) NO (or per-
oxynitrite) induced DNA damage leading to the accumulation
of p53 [5]. (B) Activation of guanylate cyclase, promoting
apoptosis by unknown mechanisms [6]. (C) Direct activation
of the mitochondrial permeability transition pore (PTP) [7,8],
resulting in cytochrome c release and thus activation of cas-
pases via cytosolic APAF-1. (D) Peroxidation and degrada-
tion of mitochondrial phospholipids leading to loss of cyto-
chrome c from mitochondria into the cytosol [9]. (E)
Inhibition of mitochondrial respiration, resulting in oxidant
(including peroxynitrite) production and decreased membrane
potential, promoting PTP opening and cytochrome c release
[10^12]. In support of the later possibility we and others have
shown that NO is a potent inhibitor of mitochondrial respi-
ration [13], resulting in increased superoxide, hydrogen per-
oxide and peroxynitrite production [14,15], and these oxidants
can open the PTP and cause cytochrome c release [16,17].
However, interpreting previous research is complicated by
the fact that di¡erent types of NO donor molecule, with dif-
ferent chemical properties, have been used to supply NO to
cells. The two most popular types of NO donors are: the
NONOates, which are supposedly ‘pure’ NO donors, and
the S-nitrosothiols, which can release NO, but also directly
transfer the NO group to a variety of recipients particularly
reduced thiols (a process known as transnitrosylation) [18].
NONOates are adducts of NO with nucleophiles and they
dissociate spontaneously generating NO and free nucleophile
[18], thus, they are meant not to be involved in direct trans-
nitrosylation reactions. Surprisingly most research on NO-in-
duced apoptosis has been done using nitrosothiols (such as
SNAP and nitrosoglutathione) as NO donors [7,8,19^24].
This complicates the interpretation of the work because nitro-
sothiols can transnitrosylate thiols in metabolites (such as
glutathione - resulting in glutathione depletion) and accessible
thiols in many if not most proteins (resulting in changes in
protein function) [25].
In the work described here we sought to determine the
extent to which two di¡erent types of NO donors, nitroso-
thiols and NONOates, induce caspase activation by opening
of the PTP or inhibition of mitochondrial respiration. We
show that nitrosothiols, NONOates and mitochondrial inhib-
itors activate caspases by di¡erent mechanisms, and this has
immediate importance for understanding the means by which
NO causes apoptosis.
2. Materials and methods
2.1. Materials
S-Nitroso-N-acetylpenicillamine (SNAP), spermine-NONOate,
DEVD-7-amino-4-methyl-coumarin (DEVD-amc), IETD-amc were
from Alexis; diethylenetriamine/NO adduct (NOC-18 or DETA-
NONOate) - from RBI, cyclosporin A - from Calbiochem; S-nitro-
soglutathione (GSNO), 1,2-bis(2-aminophenoxy)-ethane-N,N,NP,NP-
tetra-acetic acid tetrakis(acetoxymethyl)ester (BAPTA-AM) and other
reagents were from Sigma.
2.2. Measurement of mitochondrial swelling and cytochrome c release
from isolated mitochondria
Rat heart mitochondria were prepared as described previously [17].
For measurement of mitochondrial swelling and cytochrome c release,
mitochondria (1 mg protein per 1 ml incubation bu¡er) were incu-
bated at 37‡C in the medium containing 110 mM KCl, 10 mM Tris^
HCl (pH 7.2), 5 mM KH2PO4, 50 mM creatine, 2.24 mM MgCl2,
5 mM succinate, 1 WM rotenone, 20 WM ATP or ADP (where indi-
cated), 0.1 mM CaCl2 (in some experiments it was omitted, see ¢gure
legend). To stabilise free Ca2 at 5 WM concentration, 5 mM nitrilotri-
acetic acid was added (free Ca2 was calculated as described in [26]).
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After 2 min preincubation, NO donors at 1 mM concentration were
added to mitochondria. Mitochondrial swelling was determined as
decrease in absorbance at 540 nm during 15 min of incubation. Super-
natants of mitochondria (13 000 rpmU3 min in an Eppendorf centri-
fuge) were obtained after 15 min incubation and the ascorbate-re-
duced-minus-ferricyanide-oxidised absorption di¡erence spectra of
supernatants were recorded with Hitachi U-2000 spectrophotometer.
Cytochrome c content was estimated as described in [27].
2.3. Cell culture
Murine macrophage J774 cells were maintained in DMEM supple-
mented with 10% foetal calf serum and 1% streptomycin+1% penicil-
lin at 37‡C in a humidi¢ed atmosphere containing 5% CO2. For the
experiments, cells (2^3U107) were suspended in 8 ml of DMEM with
5% foetal calf serum and incubated with indicated NO donors (at
1 mM concentration) or inhibitors of the respiratory chain: 2 mM
azide, 2 WM rotenone or 2 WM myxothiazol. When cyclosporin A
(3 WM), ascomycin (3 WM) or BAPTA-AM (6 WM) were used, cells
were preincubated for 30 min with indicated compounds before NO
donors or respiratory inhibitors were added.
NO levels and oxygen consumption were determined using speci¢c
electrodes, as described previously [13].
2.4. Measurement of caspase activity
Cells were sedimented at 700UgU3 min, washed with Krebs^
HEPES bu¡er (pH 7.4) and resuspended in 200 Wl of lysing bu¡er
containing 100 mM HEPES (pH 7.4), 10% sucrose, 0.1% CHAPS,
1 mM EDTA, 10 mM DTT, 5 Wl protease inhibitor cocktail (Sigma).
After 20 min on ice, cells were disrupted by passing 15 times through
27G needle and centrifuged at 13 000 rpmU10 min. Supernatants (50^
100 Wg total protein) were incubated with 100 WM DEVD-amc or
IETD-amc for 60 min. Substrate cleavage was determined £uoromet-
rically (excitation at 380 nm, emission at 460 nm). DEVD-CHO,
1 WM, and IETD-CHO, 1 WM, were used to inhibit caspase activity
and to ensure speci¢city of the reaction. 10^200 nM 7-amino-4-meth-
yl-coumarin was used for calibration of £uorescence signal.
3. Results
3.1. E¡ect of NO donors on cytochrome c release from isolated
mitochondria
We wanted to determine what types of NO donors caused
PTP and cytochrome c release from isolated mitochondria
and by what means. Fig. 1 shows that incubation of isolated
heart mitochondria with the nitrosylating NO donors SNAP
or GSNO in the presence of 5 WM free Ca2 resulted in the
release of cytochrome c from mitochondria. The release of
cytochrome c was inhibitable by cyclosporin A, a speci¢c in-
hibitor of the PTP, and was accompanied by mitochondrial
swelling suggesting that it was related to opening of PTP.
SNAP- and GSNO-induced mitochondrial swelling and re-
lease of cytochrome c was observed only in the presence of
Ca2 and low, 20 WM, concentrations of ATP or ADP where-
as higher concentrations of ATP (100 WM) completely sup-
pressed both swelling and cytochrome c release (not shown).
The non-nitrosylating NO donor NOC-18 (DETA-NONOate)
or a speci¢c inhibitor of cytochrome oxidase azide, had little
or no e¡ect on swelling and cytochrome c release (Fig. 1). At
the concentrations used all the NO donors almost completely
inhibited respiration (data not shown), due to NO inhibition
of cytochrome oxidase [9,11], but since a more speci¢c inhib-
itor of cytochrome oxidase, azide, did not cause pore opening,
the NO donors can not have caused pore opening and cyto-
chrome c release due to respiratory inhibition. We also com-
pared the levels and the time-course of NO release to the
incubation medium by various NO donors. The NO concen-
tration reached a steady state after 5^8 min for all NO do-
nors. Since the steady state concentration of NO produced
over the incubation time by NOC-18 (0.89^1.5 WM) was sim-
ilar to that produced by SNAP (0.66^1.34 WM) or GSNO
(1.60^1.90 WM), but NOC-18 (and authentic NO [17]) failed
to cause pore opening and cytochrome c release, these action
of SNAP and GSNO can not be due to NO alone, but most
likely involves their nitrosylating activity.
3.2. NO donors induce activation of caspases in macrophages
The release of cytochrome c from mitochondria can initiate
activation of apoptotic proteases - caspases leading to cell
death. We investigated whether NO donors can induce acti-
vation of caspases in the macrophage J774 cell line. Fig. 2
shows that exposure of cells to 1 mM GSNO, SNAP or
NOC-18 resulted in activation of caspase-3-like-proteases
(DEVD-cleaving activity) and caspase-3-processing proteases
(IETD-cleaving activity). That was evident within 4 h of ex-
posure and continued to increase through a further 4 h of
incubation. The events leading to caspase activation require
at least 1^2 h of incubation of cells with NO donors, as if
SNAP or NOC-18 were removed from cells within that peri-
od, no signi¢cant increase in activity of caspases was observed
during a further 4^5 h incubation (data not shown). Activa-
tion of caspases was also prevented by 1 mM oxyhemoglobin:
Fig. 1. E¡ect of NO donors on mitochondrial swelling (A) and re-
lease of cytochrome c (B). Isolated heart mitochondria were incu-
bated with 1 mM GSNO, 1 mM SNAP, 1 mM NOC-18 or 2 mM
azide in the presence of indicated compounds while assessing de-
crease in absorption at 540 nm. Mitochondrial swelling is expressed
as decrease in absorption after 15 min incubation if compared to
change in absorption caused by 0.1 mM CaCl2 and 15 mM phos-
phate (100% swelling). Supernatants obtained after 15 min incuba-
tions were used for spectrophotometric determination of released cy-
tochrome c.
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DEVD-cleaving activity after 6 h incubation of cells with
SNAP or NOC-18 and oxy-hemoglobin was 0.034 þ 0.003
and 0.042 þ 0.025 nmol/min/mg protein, respectively, and
was not signi¢cantly di¡erent from control cells (see Fig.
2A), presumably due to the ability of oxyhemoglobin to scav-
enge NO or NO. Inhibitors of the mitochondrial respiratory
chain, azide and myxothiazol, at concentrations that com-
pletely inhibited cell respiration, were less e¡ective in caspase
activation: increase in IETD- and DEVD-cleaving activity
was observed only after 6 and 8 h of incubation, respectively.
This suggests that the caspase activation induced by NO do-
nors can not be due solely to respiratory inhibition. Oligomy-
cin, an inhibitor of mitochondrial ATPase, did not induce
signi¢cant activation of caspases even after 8 h of incubation.
3.3. Nitrosylating NO donors-induced activation of caspases is
blocked by cyclosporin A and chelation of intracellular
calcium
In order to test whether the caspase activation caused by
the NO donors and respiratory inhibitors was due to PTP, we
tested whether this activation could be blocked by the PTP
inhibitor cyclosporin A. As can be seen from Fig. 3, cyclo-
Fig. 2. Time-course of NO donors (A,C) and the respiratory inhibitors (B,D) induced activation of caspases in macrophages. Cells were treated
for di¡erent periods of time with 1 mM GSNO, 1 mM SNAP, 1 mM NOC-18, 2 mM azide, 2 WM myxothiazol or 1 Wg/ml oligomycin. Cell ly-
sates were then prepared and incubated 60 min with £uorogenic peptides: DEVD-amc (A,B) or IETD-amc (C,D). The £uorescence of the prod-
uct of reaction, amc, was measured in 1 ml of bu¡er containing 10 mM HEPES, 10% sucrose and 0.1% bovine serum albumin, pH 7.4.
Table 1
Cyclosporin A and chelation of intracellular calcium does not prevent activation of caspases in macrophages induced by the respiratory chain
inhibitors
Incubation conditions DEVD-cleaving activity (nmol/min/mg) IETD-cleaving activity (nmol/min/mg)
Control 0.031 þ 0.010 0.084 þ 0.022
Azide, 2 mM 0.154 þ 0.040 0.211 þ 0.043
+cyclosporin A, 3 WM 0.144 þ 0.034 0.114 þ 0.025
+BAPTA-AM, 6 WM 0.155 þ 0.039 0.165 þ 0.026
Myxothiazol, 2 WM 0.102 þ 0.017 0.239 þ 0.051
+cyclosporin A, 3 WM 0.066 þ 0.023 0.104 þ 0.024*
+BAPTA-AM, 6 WM 0.110 þ 0.013 0.170 þ 0.042
Rotenone, 2 WM 0.125 þ 0.019 0.192 þ 0.022
+cyclosporin A, 3 WM 0.168 þ 0.047 0.159 þ 0.011
+BAPTA-AM, 6 WM 0.163 þ 0.038 0.192 þ 0.046
Cells were incubated with the respiratory chain inhibitors for 8 h. Cyclosporin A and BAPTA-AM were added to the cells 30 min before the
inhibitors. Data are means þ S.E.M. from at least three independent experiments. * - Signi¢cant di¡erence from control (P6 0.05).
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sporin A completely prevented DEVD- and IETD-cleaving
activity in macrophages incubated with nitrosylating NO do-
nors GSNO and SNAP, whereas it had no signi¢cant e¡ect in
the case of NOC-18 and spermine-NONOate. Preincubation
of cells with ascomycin, which inhibits calcineurin but not
PTP, had no e¡ect on SNAP- or NOC-18-induced activation
of caspases, indicating that calcineurin had no signi¢cant role
in the activation of caspases. Cyclosporin A had no e¡ect on
DEVD-cleaving activity induced by the respiratory chain in-
hibitors, however it signi¢cantly reduced IETD-cleavage in-
duced by myxothiazol (Table 1). Nitrosylating NO donors-
induced activation of caspases also was completely prevented
by BAPTA, a chelator of intracellular Ca2, and to some
extent by EGTA which binds extracellular Ca2 (Fig. 4). Che-
lation of intracellular Ca2 had no signi¢cant e¡ect in the case
of NOC-18 and the respiratory chain inhibitors induced acti-
vation of caspases (Fig. 4 and Table 1). Altogether the data
suggest that nitrosylating NO donors-induced activation of
caspases is mediated by mitochondria via opening of PTP
pore, whereas the caspase activation induced by ‘pure’ NO
donors NOC-18 and spermine-NONOate and by the respira-
tory inhibitors involves the PTP only partially or not at all.
4. Discussion
In isolated mitochondria we found that the nitrosothiols
SNAP and GSNO could induce cyclosporin A-sensitive PTP
opening and cytochrome c release, in the presence of calcium,
whereas NO and NOC-18 could not. This suggests that nitro-
sothiols may open the pore by means other than NO produc-
tion alone. Hortelano et al. [7] reported that NO could induce
pore opening in isolated mitochondria, using conditions sim-
ilar to those used here. However, as NO donors they used
SNAP and GSNO, which are nitrosothiols, and SIN-1, which
is a donor of both NO and superoxide, and thus produces
peroxynitrite (a known pore opener) [16]. Balakirev et al [8]
used photolysis of a nitrosothiol (S-nitroso-N-acetylcysteine)
to generate NO with isolated mitochondria, and found that
this halved the lag-time before PTP induced by high calcium.
However, it is di⁄cult to know what other products might be
generated by photolysis of nitrosothiols. We do not know
how nitrosothiols induce PTP. Possibilities include: direct
transnitrosylation of thiols known to be involved in control-
ling pore opening, or oxidation of intra-mitochondrial gluta-
thione.
In macrophages all NO donors induced caspase activation
to a similar extent and with a similar time course. However,
cyclosporin A and calcium chelators, which block the PTP,
prevented caspase activation by the nitrosothiols, but were
much less e⁄cient at preventing caspase activation induced
by the NONOates. Hortelano et al. [7,24] found that cyclo-
sporin A blocked apoptosis in thymocytes and caspase acti-
vation in macrophages, but this was induced by 0.2^1 mM
GSNO. This is consistent with the nitrosothiols directly acti-
vating the pore, whereas NO itself does not.
The three di¡erent mitochondrial respiration inhibitors
Fig. 3. E¡ect of cyclosporin A on activity of caspases in macro-
phages induced by NO donors. Cells were incubated 6 h with NO
donors (all of them at 1 mM concentration) in the presence or ab-
sence of 3 WM cyclosporin A or 3 WM ascomycin. * - Statistically
signi¢cant e¡ect of cyclosporin A if compared to treatment with
NO donor alone.
Fig. 4. E¡ect of Ca2 chelators on NO donors-induced activation of
caspases in macrophages. Cells were incubated 6 h in the presence
of SNAP or NOC-18 in the presence or absence of 6 WM cell per-
meable calcium chelator BAPTA-AM. In the experiments where
cells were treated with GSNO, 2 mM EGTA was used as chelator
of extracellular calcium. * - Statistically signi¢cant e¡ect of BAP-
TA-AM if compared to treatment with NO donor alone.
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caused caspase activation to a similar extent and with a sim-
ilar time course, and this activation was relatively insensitive
to cyclosporin A and calcium chelators. This suggests that
mitochondrial inhibition induces caspase activation not pri-
marily by PTP opening. Oligomycin, which inhibits the mito-
chondrial ATPase, did not cause any caspase activation, sug-
gesting that the respiratory inhibitors did not cause caspase
activation primarily by inhibition of ATP production. How-
ever, it is possible that respiratory inhibition might cause a
greater fall in cellular ATP/ADP than inhibition of the ATP
synthase, since the former will cause the ATP synthase to
reverse hydrolysing ATP generated by glycolysis.
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